Recently, in patients with compensated HF, intravenous (IV) administration of allogeneic UC-MSCs and BM-MSCs led to a remarkable increase in the expression of hepatocyte growth factor (HGF), finally causing myogenesis and suppression of inflammation (Bartolucci et al., 2017[9]). The gene discussed is HGF; the disease is hydrops fetalis.